[Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog]

Standard

[Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog]. / Sputtek, Andreas; Langer, R; Schmid, H; Steigerwald, R; Trenkel, K; Kron, W; Henrich, H A; Körber, C; Rau, G.

in: Beitr Infusionsther, Jahrgang 30, 1992, S. 292-296.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Sputtek, A, Langer, R, Schmid, H, Steigerwald, R, Trenkel, K, Kron, W, Henrich, HA, Körber, C & Rau, G 1992, '[Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog]', Beitr Infusionsther, Jg. 30, S. 292-296. <http://www.ncbi.nlm.nih.gov/pubmed/1284719?dopt=Citation>

APA

Sputtek, A., Langer, R., Schmid, H., Steigerwald, R., Trenkel, K., Kron, W., Henrich, H. A., Körber, C., & Rau, G. (1992). [Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog]. Beitr Infusionsther, 30, 292-296. http://www.ncbi.nlm.nih.gov/pubmed/1284719?dopt=Citation

Vancouver

Sputtek A, Langer R, Schmid H, Steigerwald R, Trenkel K, Kron W et al. [Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog]. Beitr Infusionsther. 1992;30:292-296.

Bibtex

@article{1fca5d862365466494934ec2489541db,
title = "[Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog]",
abstract = "Although the effectiveness of hydroxyethyl starch (HES) as a cryoprotectant for human red blood cells (HRBC) is well known, no clinical application has evolved so far. In contrast to glycerol HES has the advantage of causing no hemolysis per se. This offers the opportunity of a one-step procedure without a time consuming postthaw washing procedure prior to transfusion. In this study the in vitro results obtained with red blood cells from 8 dogs (DRBC) are reported and compared to HRBC (n = 5). It turned out that DRBC had a similar 2,3-DPG and a lower ATP content. Postthaw survival in terms of saline stability differed markedly (67 +/- 6 and 86 +/- 2%, respectively). DRBC were more susceptible to hypotonic stress than HRBC. Nevertheless, after cryopreservation 91% (HRBC) and 92% (DRBC) of the original 2,3-DPG were found in the thawed RBC concentrates.",
author = "Andreas Sputtek and R Langer and H Schmid and R Steigerwald and K Trenkel and W Kron and Henrich, {H A} and C K{\"o}rber and G Rau",
year = "1992",
language = "Deutsch",
volume = "30",
pages = "292--296",

}

RIS

TY - JOUR

T1 - [Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog]

AU - Sputtek, Andreas

AU - Langer, R

AU - Schmid, H

AU - Steigerwald, R

AU - Trenkel, K

AU - Kron, W

AU - Henrich, H A

AU - Körber, C

AU - Rau, G

PY - 1992

Y1 - 1992

N2 - Although the effectiveness of hydroxyethyl starch (HES) as a cryoprotectant for human red blood cells (HRBC) is well known, no clinical application has evolved so far. In contrast to glycerol HES has the advantage of causing no hemolysis per se. This offers the opportunity of a one-step procedure without a time consuming postthaw washing procedure prior to transfusion. In this study the in vitro results obtained with red blood cells from 8 dogs (DRBC) are reported and compared to HRBC (n = 5). It turned out that DRBC had a similar 2,3-DPG and a lower ATP content. Postthaw survival in terms of saline stability differed markedly (67 +/- 6 and 86 +/- 2%, respectively). DRBC were more susceptible to hypotonic stress than HRBC. Nevertheless, after cryopreservation 91% (HRBC) and 92% (DRBC) of the original 2,3-DPG were found in the thawed RBC concentrates.

AB - Although the effectiveness of hydroxyethyl starch (HES) as a cryoprotectant for human red blood cells (HRBC) is well known, no clinical application has evolved so far. In contrast to glycerol HES has the advantage of causing no hemolysis per se. This offers the opportunity of a one-step procedure without a time consuming postthaw washing procedure prior to transfusion. In this study the in vitro results obtained with red blood cells from 8 dogs (DRBC) are reported and compared to HRBC (n = 5). It turned out that DRBC had a similar 2,3-DPG and a lower ATP content. Postthaw survival in terms of saline stability differed markedly (67 +/- 6 and 86 +/- 2%, respectively). DRBC were more susceptible to hypotonic stress than HRBC. Nevertheless, after cryopreservation 91% (HRBC) and 92% (DRBC) of the original 2,3-DPG were found in the thawed RBC concentrates.

M3 - SCORING: Zeitschriftenaufsatz

VL - 30

SP - 292

EP - 296

ER -